Allarity Therapeutics, Inc. Cash Equivalents, at Carrying Value
Allarity Therapeutics, Inc. (ALLR) had Cash Equivalents, at Carrying Value of $0 as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-03-30
- 2025-12-31: Cash Equivalents, at Carrying Value $0.00.
- 2025-09-30: Cash Equivalents, at Carrying Value $0.00.
- 2025-06-30: Cash Equivalents, at Carrying Value $0.00.
- 2025-03-31: Cash Equivalents, at Carrying Value $0.00.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-15 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-09 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-30 |
| 2024-09-30 | $18.46M 10-Q · filed 2024-11-14 |
| 2023-12-31 | $166.00K 10-Q · filed 2024-11-14 |
| 2021-09-30 | $5.58M 10-Q/A · filed 2022-05-17 |
| 2020-12-31 | $298.00K 10-Q/A · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |